Structure Therapeutics American Stock Price Prediction
| GPCR Stock | 33.75 0.01 0.03% |
Oversold Vs Overbought
46
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (0.78) | EPS Estimate Next Year (0.63) | Wall Street Target Price 85.8182 | EPS Estimate Current Quarter (0.19) |
Using Structure Therapeutics hype-based prediction, you can estimate the value of Structure Therapeutics American from the perspective of Structure Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Structure Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Structure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Structure Therapeutics after-hype prediction price | USD 33.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Structure |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Structure Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Structure Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Structure Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Structure Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Structure Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Structure Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Structure Therapeutics' historical news coverage. Structure Therapeutics' after-hype downside and upside margins for the prediction period are 29.55 and 37.95, respectively. We have considered Structure Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Structure Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Structure Therapeutics is based on 3 months time horizon.
Structure Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Structure Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Structure Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Structure Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 4.24 | 0.07 | 0.03 | 8 Events / Month | 11 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
33.75 | 33.75 | 0.00 |
|
Structure Therapeutics Hype Timeline
Structure Therapeutics is currently traded for 33.75. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of -0.03. Structure is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.11%. %. The volatility of related hype on Structure Therapeutics is about 1431.69%, with the expected price after the next announcement by competition of 33.72. About 95.0% of the company shares are owned by institutional investors. The book value of Structure Therapeutics was currently reported as 9.76. The company recorded a loss per share of 2.16. Structure Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Structure Therapeutics Basic Forecasting Models to cross-verify your projections.Structure Therapeutics Related Hype Analysis
Having access to credible news sources related to Structure Therapeutics' direct competition is more important than ever and may enhance your ability to predict Structure Therapeutics' future price movements. Getting to know how Structure Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Structure Therapeutics may potentially react to the hype associated with one of its peers.
Structure Therapeutics Additional Predictive Modules
Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Structure Therapeutics Predictive Indicators
The successful prediction of Structure Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Structure Therapeutics American, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Structure Therapeutics based on analysis of Structure Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Structure Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Structure Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 12.62 | 7.16 | 19.14 | 10.31 | Net Debt To EBITDA | 0.002782 | 1.73 | 1.21 | 1.27 |
Story Coverage note for Structure Therapeutics
The number of cover stories for Structure Therapeutics depends on current market conditions and Structure Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Structure Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Structure Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Structure Therapeutics Short Properties
Structure Therapeutics' future price predictability will typically decrease when Structure Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Structure Therapeutics American often depends not only on the future outlook of the potential Structure Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Structure Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.7 M | |
| Cash And Short Term Investments | 467.3 M |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.